⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockSwitzerlandNasdaqGS

NVCR

NovoCure Limited

Healthcare · Medical Devices

14.68USD

-0.4200 (-2.78%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on NVCR.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 14.68
P/E—
Dvd Ind Yld0.0%
P/B5.06
P/S2.4
Curr EV/T12M EBITDA-11.0
Mkt Cap (USD)1.7B
Curr EV (USD)1.5B
2)

Per Share Data

EPS T12M-1.30
DPS0.00
Bk Val Per Sh2.90
Rev/Sh6.03
Cash/Sh3.78
Curr Shares Out116.4M
FCF/Sh-0.22
3)

Cash Flow Analysis

P/CF-607.3
Curr P/FCF-67.2
CF/NI0.0
Dvd P/O0.0%
Cash Gen/Cash Reqd-0.1
Csh Dvd Cov—
CFO/Sales-0.4%
Eff Interest Rate5.8%
4)

Growth Potential

Dil EPS 1Y Gr21.8%
Cap 1Y Gr17.1%
BPS 1Y Gr-8.6%
R&D To Sales32.1%
Retention Rate100.0%
Rev 1Y Gr8.3%
FCF 1Y Gr-9.3%
Assets 1Y Gr-35.2%
5)

Profitability

EBITDA-0.1B
EBIT-0.2B
Operating Margin-22.1%
Pretax Margin-21.8%
Net Margin-21.2%
ROA-14.6%
ROE-43.2%
ROC-26.3%
Asset Turnover0.69
6)

Structure

Current Ratio2.89
Quick Ratio2.66
Debt/Assets29.4%
Debt/Com Eq69.0%
Net Debt/EBITDA-1.01
Tot Debt/Capital40.8%
Gross Margin76.1%
EBIT/Int Exp-6.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.